Companies โ€บ Kymab

Kymab

Healthcare ๐Ÿ“ Cambridge, United Kingdom ๐Ÿ‘ฅ 11-50 employees ๐Ÿ’ฐ $120.4M raised ๐Ÿ“… Founded 2009

Kymab Limited discovers, develops, and commercializes human therapeutic monoclonal antibodies for the treatment of human diseases using its proprietary Kymouse platform. Its platform captures the diversity of the B lymphocyte component of the human immune system and generates human antibody-based biopharmaceuticals dir

๐Ÿ“Š Company Overview

Sector
Healthcare
Country
United Kingdom
Employees
11-50
Total Raised ยท Venture
$120.4M
Founded
2009
Cloud
Unknown
Email
Mimecast

โ˜๏ธ Cloud Infrastructure

WorkspaceMimecast
CDN๐Ÿ”’ Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

๐Ÿ’ฐ Estimated Cloud Spend

$108K โ€“ $270K / year across cloud providers

๐Ÿ›  Tech Stack & Marketing

Ad Platforms๐Ÿ”’ Subscribers only
Analytics & CRM๐Ÿ”’ Subscribers only
CMS / Platform๐Ÿ”’ Subscribers only
Frontend Stack๐Ÿ”’ Subscribers only

Detected from Kymab's public homepage as of 2026-06-13.

๐Ÿ” Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 ยท Methodology ยท Suggest a correction